Clinical Trial Update: A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer [NA]

View source ↗

Summary

A pilot preoperative trial of ganetespib with paclitaxel for triple-negative breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Ganetespib (ganetespib)

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | NA | Status: WITHDRAWN